Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
Fecha de publicación :
2020
Nota:
This is an open access article
distributed under the terms of the CC-BY-NC-ND
License. © 2020 Yau T et al.JAMA Oncology
Cita:
Yau, T. (Thomas); Kang, Y.K. (Yoon-Koo); Kim, T.Y. (Tae-You); et al. "Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial". JAMA Oncology. 6 (11), 2020,
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.